DE BARTOLOMEIS, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 4.391
NA - Nord America 3.554
AS - Asia 2.488
SA - Sud America 428
AF - Africa 126
OC - Oceania 1
Totale 10.988
Nazione #
US - Stati Uniti d'America 3.440
RU - Federazione Russa 2.101
SG - Singapore 1.290
IT - Italia 944
HK - Hong Kong 531
CN - Cina 501
BR - Brasile 392
DE - Germania 281
FI - Finlandia 231
UA - Ucraina 166
IE - Irlanda 150
NL - Olanda 142
GB - Regno Unito 104
CI - Costa d'Avorio 96
CA - Canada 90
FR - Francia 77
SE - Svezia 73
AT - Austria 35
VN - Vietnam 27
KR - Corea 26
IN - India 22
ZA - Sudafrica 18
BD - Bangladesh 17
ES - Italia 17
MX - Messico 14
TR - Turchia 14
BE - Belgio 12
PK - Pakistan 9
PL - Polonia 9
IS - Islanda 8
JP - Giappone 8
AR - Argentina 7
BG - Bulgaria 7
CL - Cile 7
CZ - Repubblica Ceca 7
EC - Ecuador 7
LT - Lituania 7
HU - Ungheria 6
IQ - Iraq 6
PE - Perù 6
UZ - Uzbekistan 6
HN - Honduras 5
IR - Iran 5
TW - Taiwan 5
VE - Venezuela 5
CO - Colombia 4
ID - Indonesia 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
GR - Grecia 3
JM - Giamaica 3
NG - Nigeria 3
OM - Oman 3
SI - Slovenia 3
EG - Egitto 2
SA - Arabia Saudita 2
AL - Albania 1
AU - Australia 1
BN - Brunei Darussalam 1
CH - Svizzera 1
DZ - Algeria 1
ET - Etiopia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MV - Maldive 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 10.988
Città #
Singapore 782
Moscow 560
Hong Kong 522
Chandler 443
Santa Clara 294
Millbury 204
Naples 176
Jacksonville 172
Ashburn 147
Princeton 145
Nanjing 114
Beijing 112
Amsterdam 104
Wilmington 88
Boston 83
Norwalk 78
Des Moines 75
Houston 73
Ottawa 61
Seattle 58
Napoli 56
Rome 51
Helsinki 46
Nanchang 45
Munich 44
Turku 44
Hefei 42
Woodbridge 41
Nuremberg 37
Lawrence 34
Milan 29
Falkenstein 28
Shenyang 28
São Paulo 28
Hebei 27
Frankfurt am Main 25
Dong Ket 24
Jiaxing 23
Seoul 23
Changsha 20
Falls Church 20
Kronberg 20
London 17
Düsseldorf 16
Portici 16
Brooklyn 15
Los Angeles 15
Belo Horizonte 14
Boardman 14
Dublin 13
Subottsi 13
New York 12
San Francisco 12
Toronto 12
Brussels 11
Catania 11
The Dalles 11
Brasília 10
Tianjin 10
Vienna 10
Atlanta 9
Kunming 9
Redwood City 9
Aversa 8
Bari 8
Cambridge 8
Lauterbourg 8
Ortona 8
Rio de Janeiro 8
Rochdale 8
Salvador 8
Xi'an 8
Bexley 7
Fairfield 7
Johannesburg 7
Kochi 7
Lappeenranta 7
Mexico City 7
Montreal 7
Paris 7
Reykjavík 7
Turin 7
Cagliari 6
Chicago 6
Council Bluffs 6
Florence 6
Guangzhou 6
Monza 6
Porto Alegre 6
Roubaix 6
Tashkent 6
Casoria 5
Concordia Sagittaria 5
Denver 5
Gallipoli 5
Genoa 5
Genova 5
Guarulhos 5
Indiana 5
Olomouc 5
Totale 5.526
Nome #
Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia 98
Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis 86
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 84
Transcranial direct current stimulation for obsessive–compulsive disorder: A randomized, controlled, partial crossover trial 83
The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment 81
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 80
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 80
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 79
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 79
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 75
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 74
Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis 73
Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice 72
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs 72
Cognitive correlates of borderline intellectual functioning in borderline personality disorder 72
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables 71
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 71
Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia. 70
M170. GENETIC CHARACTERIZATION OF A COHORT OF PATIENTS AFFECTED BY SCHIZOPHRENIA. THE ROLE FOR RARE STRUCTURAL VARIANTS IN MODULATING TREATMENT RESISTANT ENDOPHENOTYPES: PRELIMINARY DATA 70
Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials 69
Acute administration of antipsychotics modulates Homer striatal gene expression differentially 69
Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis. 69
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 68
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients 68
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 68
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 68
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 67
Meccanismi convergenti e divergenti nel dolore e nella depressione 67
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. 67
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 67
Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders 66
The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment 65
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation 65
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor 65
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 65
Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine 64
d-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice 64
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 64
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 64
Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors 64
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients 64
Antypsychotic induced gene expression in the rat brain: a computational and experimental approach 63
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 63
Cerebellar transcranial direct current stimulation in children with autism spectrum disorder: A pilot study on efficacy, feasibility, safety, and unexpected outcomes in tic disorder and epilepsy 63
Dopaminergic regulation of epileptic activity. 62
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 62
Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder 62
L'Araba Fenice delle psicosi: rinascita e trasformazione dell'ipotesi dopaminergica 61
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins 61
Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia. 61
Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder 61
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 60
Neurobiological correlates of anxiety treatment.(Le basi neurobiologiche della terapia dell’ansia) 60
Dandy-Walker Syndrome with psychotic symptoms: A case report 60
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 60
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 60
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications 60
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 59
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 59
The Psychiatric Neuromodulation Unit: Implementation and Management 59
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention 59
Fisiopatologia cellulare e molecolare 58
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 58
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 58
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses 58
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 58
Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis 58
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia 58
Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach 57
Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain 57
Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins 57
Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain. 56
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. 56
Disturbo da uso di alcol 56
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 56
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression 56
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 56
Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus. 55
A Homer 1 gene variant influences brain structure and function, lithium effects on white matter, and antidepressant response in bipolar disorder: A multimodal genetic imaging study 55
Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. 54
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients 54
Acute administration of antipsychotics modulates Homer striatal gene expression differentially. 53
Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice. 53
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 53
Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression 53
Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials 52
Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings 52
Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action 52
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews 52
Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases 52
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment 52
Neural substrates of verbal memory impairment in schizophrenia: A multimodal connectomics study 51
Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study 51
Depression and Anxiety Symptoms "Among the Waves" of the COVID-19 Pandemic in Obsessive Compulsive Disorder and Adjustment Disorder Patients 51
Striatal expression of Homer1a is affected by genotype but not dystonic phenotype of tottering mice: a model of spontaneously occurring motor disturbances 51
Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia 51
Cariprazine (RGH-188): A new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 51
Transcranial Direct Current Stimulation in Obsessive-Compulsive Disorder, Posttraumatic Stress Disorder, and Anxiety Disorders 51
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia 51
Psychiatric Symptoms in Parkinson’s Disease Patients before and One Year after Subthalamic Nucleus Deep Brain Stimulation Therapy: Role of Lead Positioning and Not of Total Electrical Energy Delivered 50
Totale 6.255
Categoria #
all - tutte 47.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 0 0 0 0 0 0 0 61
2020/2021515 35 30 60 42 43 97 44 3 76 21 36 28
2021/2022971 14 1 8 11 8 48 22 32 162 79 163 423
2022/20231.187 193 95 35 49 138 160 14 108 159 103 89 44
2023/20241.016 33 146 92 92 59 51 60 161 35 26 168 93
2024/20256.079 322 423 16 55 170 320 717 444 487 653 2.225 247
Totale 11.344